Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer.

Lingpeng YangYang HeZifei ZhangWentao Wang

Published in: BioMed research international (2020)

CEP55 may serve as a candidate treatment target for it is a determinant of prognosis and immune infiltration in liver cancer patients. DNA hypomethylation might contribute to the overexpression of CEP55 in liver cancer.

Keyphrases

cell proliferation
circulating tumor
poor prognosis
cell free
transcription factor
nucleic acid